Drug Trial News

RSS

COLD-fX reduces colds

The results of a new study to be published in the Canadian Medical Association Journal show that COLD-fX, an anti-flu, anti-cold pill, reduced the incidence and frequency of recurrent colds by more than half. It also cut the duration of colds and significantly reduced their severity.

25 Oct 2005

Elderly people with the lowest and highest hemoglobin concentrations are at increased risk of death

Increasing evidence indicates that anemia is common in the elderly population, but few studies have assessed the association of anemia with clinical outcomes, such as illness and death, according to background information in the article.

25 Oct 2005

Electronic health record-based clinical trial alert system increases recruitment rates

An electronic health record-based clinical trial alert system increased recruitment rates and physicians' participation in an ongoing clinical trial, according to a study in the October 24 issue of Archives of Internal Medicine.

25 Oct 2005

Botox injections relieve severe facial pain

According to a doctor in Brazil the excruciating pain associated with inflammation of the trigeminal nerve of the head and face can be substantially relieved by injections of botulinum toxin A.

25 Oct 2005

New whooping cough vaccine for adolescents and adults

In the first study of its kind, researchers at Saint Louis University have demonstrated that immunization with a new vaccine could potentially prevent more than a million cases of pertussis (whooping cough) each year in adolescents and adults.

24 Oct 2005

Viagra may be the next drug treatment for heart problems

Sildenafil citrate (Viagra), a drug used to treat erectile dysfunction (ED) in millions of men, reduces the stimulatory effects of hormonal stress on the heart by half, according to results of a new study by researchers at Johns Hopkins.

24 Oct 2005

Fair treatment in the workplace associated with a reduced risk of coronary heart disease

A sense of fair treatment in the workplace was associated with a reduced risk of coronary heart disease in a large long-term study of British office workers published in the October 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

24 Oct 2005

Quality of care determines heart attack outcomes

Ninety days after acute myocardial infarction (AMI) - or heart attack - death rates for African Americans and white patients were found to be significantly higher in hospitals that disproportionately serve African-American patients than in hospitals that serve mainly white patients, according to a major new study led by researchers at Dartmouth Medical School.

24 Oct 2005

Botulinum toxin successfully treats trigeminal neuralgia

There is another use for botulinum toxin which has brought relief to some who suffer from migraines and eye spasms. Botulinum toxin can also successfully treat intense facial pain called trigeminal neuralgia, according to a study published in the October 25, 2005, issue of Neurology

24 Oct 2005

Faulty gene may identify those at risk of schizophrenia

Scientists believe they have discovered a genetic defect which could help explain the biological basis of schizophrenia.

24 Oct 2005

Early nerve damage caused by repetitive strain injuries can trigger "sick worker" syndrome

...characterized by malaise, fatigue and depression, and often mistaken for poor performance, according to a study by Ann Barr, Ph.D., and Mary Barbe, Ph.D., at Temple University's College of Health Professions.

24 Oct 2005

First study to examine chemotherapy errors in ambulatory care for cancer patients

In one of the first studies to examine chemotherapy errors in ambulatory care for cancer patients, researchers at Dana-Farber Cancer Institute (DFCI) and Brigham and Women's Hospital (BWH) have found that about three percent of chemotherapy orders in three outpatient infusion clinics studied contained mistakes.

24 Oct 2005

Survival benefits of longer-term tamoxifen use may take years to appear

The survival benefits of longer-term therapy using tamoxifen may take at least nine years to develop, according to a new study published in the December 1, 2005 issue of Cancer, a peer-reviewed journal of the American Cancer Society.

24 Oct 2005

Keep on working - you'll live longer but it may not be so much fun!

If you're thinking of taking early retirement, with the plan of getting into the garden, sorting out your golf or tennis or just contemplating your navel, think again!

24 Oct 2005

Possible new directions for treatments for addiction to cocaine

Cocaine causes specific alterations in the brain's circuitry at a genetic level, including short-term changes that result in a high from the cocaine, as well as long-term changes seen in addiction, researchers from UT Southwestern Medical Center have found.

23 Oct 2005

Traditional medical treatment of persistent cough may not be the most effective

The reviews appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

23 Oct 2005

Protein Oct-6 is not a biological marker for schizophrenia

The protein Oct-6 is not a biological marker for schizophrenia. The results of a study published today in the open access journal BMC Psychiatry contradict previous findings and show that Oct-6, a protein involved in neurodevelopment, is normally expressed in the adult brain and cannot be used to identify patients with schizophrenia.

23 Oct 2005

Mental health professionals need to be watchful of mental health problems beyond depression in order to prevent youth suicide

WHO researchers examine which mental disorders or combinations of disorders may be most responsible for youth suicide in a new study being released in the October issue of the American Journal of Orthopsychiatry, published by the American Psychological Association (APA).

23 Oct 2005

Study shows cystic fibrosis gene mutation a risk factor for young-onset pancreatic cancer disease

Mayo Clinic researchers have found the risk of developing pancreatic cancer at a young age (under 60) to be twice as high for people who carry a mutation of the gene that causes cystic fibrosis, compared to noncarriers. Results of a pilot and follow-up study were reported Oct. 14, 2005, online in the journal Gut.

23 Oct 2005

It's safe for patients with asthma to exercise regularly

Although exercise can trigger asthma attacks in some people, a new review of studies has found that exercise improved cardiopulmonary fitness in people with asthma.

23 Oct 2005